Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
27
users have liked this narrative
8
users have commented on this narrative
76
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
97
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Pro Medicus
RO
Robbo
Community Contributor
Great Company.... but so expensive!
Pro Medicus (ASX: PME) is an Australian company that develops medical imaging software under its Visage product range. Leading medical institutions including NYU Langone, UCSF, and Mass General Brigham have publicly or semi-publicly praised the platform—often via PME-issued press releases or interviews.
View narrative
AU$133.68
FV
128.0% overvalued
intrinsic discount
-9.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
about 1 month ago
author updated this narrative
Argan
KE
Kerry
Community Contributor
Argan's Revenue Set to Soar with a 13.31% Growth in the Coming Decade
RECENT PAST AGX has consistently delivered robust revenue growth, with fiscal year 2025 revenue rising 53% year-over-year to $874.2 million and net income surging 164% to $85.5 million. In recent quarters, revenue growth has exceeded 60% year-over-year, particularly fueled by performance in its Power Services segment.
View narrative
US$284.68
FV
16.0% undervalued
intrinsic discount
13.31%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
3
users have commented on this narrative
24
users have followed this narrative
2 months ago
author updated this narrative
Whitecap Resources
ST
StjepanK
Equity Analyst and Writer
WhiteCap Is Positioned To Profit Regardless Of Trump's Policy
Key Takeaways I believe the Canadian oil and gas sector is overlooked, mainly because of Donald Trump's upcoming second term. Regardless of Trump tariff risk, which I deem overblown due to economic recoil to the American Midwest, I believe Canadians have hedged their risk, improving exporting infrastructure.
View narrative
CA$22.60
FV
55.3% undervalued
intrinsic discount
3.51%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
8
users have commented on this narrative
117
users have followed this narrative
2 months ago
author updated this narrative
Nova Ljubljanska Banka d.d
AU
AuCA
Community Contributor
Nova Ljubljanska Banka d.d will expect a 11.2% revenue boost driving future growth
The NLB Banka Vision: Achieving €2.2 Billion Revenue and €1 Billion Profit NLB Banka stands at a pivotal moment in its journey. Guided by a bold vision set forth by its Board of Directors, the bank is primed to transform into a leading financial powerhouse across Southeastern Europe (SEE).
View narrative
€169.00
FV
1.2% undervalued
intrinsic discount
8.98%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
3
users have commented on this narrative
14
users have followed this narrative
2 months ago
author updated this narrative
Advanced Micro Devices
CO
codepoet
Community Contributor
A formidable player in AI and enterprise computing.
1. Growth Engines in AI & Data Center AMD reported 36% YoY revenue growth in Q1 2025 , reaching $7.44B , with non‑GAAP EPS of $0.96 , a 55% YoY jump.
View narrative
US$155.00
FV
11.5% overvalued
intrinsic discount
8.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
Silo Pharma
CM
CMCVentures
Community Contributor
Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s
Key Takeaways Silo Pharma is advancing a diversified pipeline of innovative therapies aimed at major health challenges in Central Nervous System (CNS) disorders like PTSD, fibromyalgia, Alzheimer’s, and multiple sclerosis (MS). The company’s unique approach of combining traditional drugs with psychedelic-inspired therapies positions it to address significant gaps in the treatment landscape.
View narrative
US$6.20
FV
88.8% undervalued
intrinsic discount
234.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
6
users have commented on this narrative
95
users have followed this narrative
2 months ago
author updated this narrative
TotalEnergies Marketing Nigeria
WA
WaneInvestmentHouse
Community Contributor
TotalEnergies Marketing Nigeria Plc Projects N191.61bn Revenue for Q2 2025
TotalEnergies Marketing Nigeria Plc has released its forecast for the second quarter of 2025, projecting a revenue of N191.61 billion for the period spanning April to June 2025. Key Highlights: - Projected revenue of N191.61 billion for Q2 2025 - Gross profit of N25.7 billion, with a cost of sales of N165.9 billion - Operating profit of N7.8 billion, after deducting selling and distribution costs and administrative expenses - Net finance cost of N5.6 billion, resulting in a profit before tax of N2.1 billion - Projected net profit of N1.4 billion for Q2 2025 - Net cash inflow of N18.3 billion from operating activities.
View narrative
₦724.23
FV
11.6% undervalued
intrinsic discount
0%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
3
users have commented on this narrative
1
users have followed this narrative
about 2 months ago
author updated this narrative
Smith Micro Software
SO
SoDanSome
Community Contributor
Old, tired, lacking innovation, limited market
Boring, old, fusty SMSI eeking out an existence until the CEO throws in the towel. Ask these questions: What is the market potential for their latest software seeing that their main product is not available on all US networks, it's made for families, needed by one parent, who can be bothered to pay $10-20 (avg.) monthly for a software that their kids WON'T use - max 16m potential shoppers.
View narrative
US$1.00
FV
32.3% undervalued
intrinsic discount
6.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
14 days ago
author updated this narrative
Alphabet
MI
MichaelP
Content Lead
Trends in Cloud and Advertising Will Deliver Steady Revenue Growth
Key Takeaways Google’s dominance in search, and digital advertising industry growth will remain in tact. Cloud computing trends will support Google Cloud revenue growth Alphabet may implement AI slightly slower, but won’t fall behind Current estimates on costs per generative AI query are prohibitive to profitability Until processing power improves and makes generative AI cheaper, Google is unlikely to lose much market share.
View narrative
US$212.34
FV
5.1% undervalued
intrinsic discount
13.47%
Revenue growth p.a.
Set Fair Value
76
users have liked this narrative
1
users have commented on this narrative
46
users have followed this narrative
3 months ago
author updated this narrative
Value any company in seconds
Popular companies